Medicare Advantage Tied to Less Use of Pricey Diabetes Drugs
Data from more than 400,000 Medicare beneficiaries showed a significant link between less prescribing of SGLT2 inhibitors and GLP-1 agonists and enrollment in a Medicare Advantage plan. Medscape Medical News
Data from more than 400,000 Medicare beneficiaries showed a significant link between less prescribing of SGLT2 inhibitors and GLP-1 agonists and enrollment in a Medicare Advantage plan. Medscape Medical News